Werewolf Therapeutics, Inc. Appoints Ellen Lubman as Chief Business Officer
August 10, 2020 at 08:00 am EDT
Werewolf Therapeutics, Inc. announced the appointment of Ellen Lubman to the company's newly created position of Chief Business Officer. In this role, Ms. Lubman will oversee corporate and business development, portfolio strategic planning, financial strategy and investor relations. Ms. Lubman brings vast biopharmaceutical industry experience to the Werewolf Therapeutics team. She joins Werewolf from Impel NeuroPharma, where she was Chief Business Officer.